ADHD: The Evidence-Based Supplement Protocol

← Back to articles

Stimulant medication remains the strongest treatment for ADHD by a wide margin. But several supplements have credible RCT evidence for adjunctive symptom reduction — particularly in children with documented nutritional deficiencies and in adults seeking add-on options. The four with the strongest meta-analytic data are EPA-dominant omega-3, iron in deficiency, zinc in deficiency, and saffron in head-to-head trials against methylphenidate. None of these replace evidence-based stimulant or non-stimulant pharmacotherapy.

EPA-Dominant Omega-3, 1–2 g EPA Daily

A 2018 meta-analysis of 16 RCTs in children and adolescents with ADHD found that omega-3 supplementation produced small but statistically significant improvements in inattention and hyperactivity scores versus placebo. The effect size is roughly one-third that of stimulants but with negligible side effects. EPA-dominant blends (60:40 EPA:DHA or higher) outperform DHA-dominant in pooled analysis. The 2019 Chang RCT extended the signal to adults. See our omega-3 form guide and omega-3 dossier.

Iron Repletion — Only If Ferritin Is Low

Children with ADHD have lower mean serum ferritin than controls in multiple cross-sectional studies, and case series have shown symptom improvement with iron repletion to ferritin >30 ng/mL. A 2008 RCT in 23 children with ADHD and ferritin <30 ng/mL showed improvements on parent-rated ADHD scales after 12 weeks of ferrous sulfate. Do not supplement iron without confirmed deficiency on labs — empirical iron in non-deficient children risks overload. See our iron piece.

Zinc, 15–30 mg Daily in Deficient Populations

Zinc deficiency is more common than iron deficiency in ADHD pediatric series. Two RCTs in zinc-deficient children with ADHD showed reductions in hyperactivity-impulsivity scores. The effect is dependent on baseline zinc status — adequately replete children show no benefit. Check serum zinc before starting; supplement to repletion. See our zinc piece.

Saffron 30 mg Daily — Adults and Adolescents

A 2019 Iranian RCT in 54 adolescents compared saffron 20–30 mg daily versus methylphenidate 20–30 mg daily for six weeks. Saffron produced comparable improvements in Teacher and Parent ADHD-RS-IV scores with substantially fewer side effects. The trial is small and needs replication outside Iran, but the signal is unusually clean. See saffron depression review for the wider clinical context.

What NOT to Take

Skip "brain-boost" nootropic blends with subclinical doses of multiple herbs. Avoid bacopa monnieri at high doses in children — the trial evidence is weak and GI side effects are common. Pycnogenol has a small positive RCT signal but production quality is highly variable and we don't recommend it as a first-line adjunct. Skip megadose vitamin/mineral "ADHD formulas" — the studied dose ranges are tighter than these products provide. For the related cognition-focused stack see our brain health after 50 piece.

How to Run the Protocol

Stimulant or non-stimulant medication first if symptomatology warrants. Then check baseline serum ferritin (target >30 ng/mL) and serum zinc. Supplement those that are low. Add EPA-dominant omega-3 1–2 g EPA daily regardless. Consider saffron 30 mg daily as a 12-week trial in adults with mild-to-moderate symptoms. Re-evaluate at week 12 with the same rating scale used at baseline. See our pediatric ADHD parents' guide.